ImportancePatient perspectives are crucial in informing design of acceptable services.BackgroundThis study determined patient preferences in glaucoma care.DesignA discrete choice experiment was used to evaluate the relative importance of out‐of‐pocket costs, waiting time, continuity of care, service location and expertise.ParticipantsNinety‐eight glaucoma suspects or glaucoma patients were recruited from one public and two private clinics in Sydney.MethodsTwelve choice‐tasks were presented in random order and forced‐choice preferences were elicited. Choice data were analysed using a multinominal logit model (NLOGIT 4.0).Main Outcome MeasuresThe relative importance and the likelihood of choosing services with each attribute were determined. Willingness‐to‐pay and willingness‐to‐wait were calculated. Analyses were stratified by whether the patient attended a public or private glaucoma clinic and other demographic features.ResultsChoice was influenced by four or five attributes: greater clinician expertise, the same clinician each visit, lower out‐of‐pocket costs and shorter wait times (all P < .05). Respondents were willing to pay an additional (Australian dollars) $325 (95% confidence interval [CI] 188‐389) to see a senior eye doctor, and $87 (95% CI 60‐116) to see the same clinician each visit. Respondents were willing to wait for these attributes; however, the estimates had wide confidence intervals and were beyond the range tested. Private patients had a stronger preference for expertise and continuity of care compared to public patients.Conclusions and RelevanceExpertise and continuity of care were important to glaucoma patients in this setting, and they were willing to pay out‐of‐pocket and concede longer waiting times to secure these preferences.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.